Generic Drug Marketing strategy

The "Generic Drugs Market: 2015 - 2030 - Opportunities, Challenges, Strategies & Forecasts" report presents an in-depth assessment of the generic drugs and Analysis of key therapeutic areas and leading generic drugs including technology, economics, key trends, market drivers, challenges, investment potential, regulatory landscape, leading therapies, opportunities, future road map, Following key trends, market drivers, challenges, Analysis of key therapeutic areas and leading generic trends ,value chain, ecosystem player profiles and strategies and  Regulatory landscape of global trends throughout the globe The report also presents market size forecasts for generic drugs from 2015 through to 2030. The forecasts are segmented for over 10 therapeutic areas, 3 brand classifications, 5 regions and 25 leading countries. 

Generic drugs will account for nearly $350 Billion in revenue by the end of 2015. The market is further expected to grow at a CAGR of 12% over the next five years. As the market consolidates; larger players continue to grow their market share on the heels of acquisitions and mergers. Well established players are particularly keen to capitalize on joint ventures in untapped markets such as Japan. In order to overcome low margins, some generic drug manufacturers are venturing into the super generics opportunity. Sold for a significantly higher price than their pure generic counterparts, super generics account for 18% of all spending on generic drugs. Driven by the cost saving potential of Biosimilar drugs, a number of countries have established regulatory pathways for their approval. We estimate that approved Biosimilar drugs will account for more than $20 Billion in revenue by the end of 2020.

  • Regulatory landscape of generic drugs throughout the globe
  • Analysis of key therapeutic areas and leading generic drugs
  • Market forecasts are provided for sub markets and their subcategories
  • Following key trends, market drivers, challenges
  • Market size forecasts for generic drugs
  • In-depth assessment of the generic drugs ecosystem

Related Conference of Generic Drug Marketing strategy

Generic Drug Marketing strategy Conference Speakers